Press and News Items

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

Press

Media for editorial use

chevron_right

Press contact

Our News

View:
format_list_bulleted grid_view

04/28/2023

Cheplapharm places notes in a volume of €750m in challenging market environment

Press releases

Read more chevron_right

04/26/2023

Announcement on Pricing

Press releases

Read more chevron_right

04/24/2023

Announcement on Offering

Press releases

Read more chevron_right

04/22/2023

CHEPLAPHARM announces acquisition of Zyprexa® from Lilly

Press releases

Read more chevron_right

03/01/2023

CHEPLAPHARM strengthens portfolio with asthma treatment from AstraZeneca

Press releases

Read more chevron_right

01/23/2023

CHEPLAPHARM continues expansion in China with the acquisition of XELODA® from Roche

Press releases

Read more chevron_right

12/01/2022

Change in the Management of CHEPLAPHARM

Press releases

Read more chevron_right

11/29/2022

CHEPLAPHARM remains on growth track

Press releases

Read more chevron_right

10/25/2022

CHEPLAPHARM receives growth capital of €550 Million from two leading global investors

Press releases

Read more chevron_right

Back to top expand_less